hinders mismatch repair

National Cancer Institute researcher Eric Huang and colleagues have identified a mechanism that promotes mutations under hypoxic conditions.

Written byClementine Wallace
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

National Cancer Institute researcher Eric Huang and colleagues have identified a mechanism that promotes mutations under hypoxic conditions.1 The oxygen-deprived microenvironment of certain tumors causes genetic instabilities that stimulate tumor progression and metastasis.

Huang's team found that, under certain cellular conditions, the hypoxia-induced transcription factor HIF-1α is responsible for hindering the cell's mismatch repair (MMR) system, crucial for maintaining genetic integrity.

Working with various human cancer cell lines, the group found that HIF-1α acts by displacing Myc, the transcriptional activator of two nuclear proteins, MSH2 and MSH6. In the absence of HIF-1α, Myc activates the expression of the two compounds, which then dimerize to form the MutSα complex – one of the mammalian versions of the MMR system. In the presence of HIF-1α, Myc cannot reach the promoters, and the expression of MutSα is inhibited.

They also found that p53 is essential for the pathway to proceed. Yale University geneticist ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies